基于主协议的癌症临床试验

Japanese journal of biometrics Pub Date : 2019-01-31 DOI:10.5691/JJB.39.85

A. Hirakawa, J. Asano, Hiroyuki Sato, S. Teramukai

{"title":"基于主协议的癌症临床试验","authors":"A. Hirakawa, J. Asano, Hiroyuki Sato, S. Teramukai","doi":"10.5691/JJB.39.85","DOIUrl":null,"url":null,"abstract":"平川晃弘∗1・浅野淳一∗2・佐藤宏征∗3・手良向聡∗4 Akihiro Hirakawa∗1 , Junichi Asano∗2 , Hiroyuki Sato∗3 and Satoshi Teramukai∗4 ∗1東京大学大学院医学系研究科生物統計情報学講座 ∗2独立行政法人医薬品医療機器総合機構新薬審査第四部 ∗3独立行政法人医薬品医療機器総合機構新薬審査第五部 ∗4京都府立医科大学大学院医学研究科生物統計学 ∗1Department of Biostatistics and Bioinformatics, Graduate School of Medicine, The University of Tokyo, Tokyo 113-8654, Japan ∗2Office of New Drug IV, Pharmaceuticals and Medical Devices Agency, Tokyo 100-0013, Japan ∗3Office of New Drug V, Pharmaceuticals and Medical Devices Agency, Tokyo 100-0013, Japan ∗4Department of Biostatistics, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto 602-8566, Japan e-mail:hirakawa@m.u-tokyo.ac.jp","PeriodicalId":365545,"journal":{"name":"Japanese journal of biometrics","volume":"15 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2019-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Cancer Clinical Trials Based on Master Protocol\",\"authors\":\"A. Hirakawa, J. Asano, Hiroyuki Sato, S. Teramukai\",\"doi\":\"10.5691/JJB.39.85\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"平川晃弘∗1・浅野淳一∗2・佐藤宏征∗3・手良向聡∗4 Akihiro Hirakawa∗1 , Junichi Asano∗2 , Hiroyuki Sato∗3 and Satoshi Teramukai∗4 ∗1東京大学大学院医学系研究科生物統計情報学講座 ∗2独立行政法人医薬品医療機器総合機構新薬審査第四部 ∗3独立行政法人医薬品医療機器総合機構新薬審査第五部 ∗4京都府立医科大学大学院医学研究科生物統計学 ∗1Department of Biostatistics and Bioinformatics, Graduate School of Medicine, The University of Tokyo, Tokyo 113-8654, Japan ∗2Office of New Drug IV, Pharmaceuticals and Medical Devices Agency, Tokyo 100-0013, Japan ∗3Office of New Drug V, Pharmaceuticals and Medical Devices Agency, Tokyo 100-0013, Japan ∗4Department of Biostatistics, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto 602-8566, Japan e-mail:hirakawa@m.u-tokyo.ac.jp\",\"PeriodicalId\":365545,\"journal\":{\"name\":\"Japanese journal of biometrics\",\"volume\":\"15 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-01-31\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Japanese journal of biometrics\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5691/JJB.39.85\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Japanese journal of biometrics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5691/JJB.39.85","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 1

摘要

平川晃弘∗1・浅野淳一∗2・佐藤宏征∗3・手良向聡∗4 Akihiro Hirakawa∗1 , Junichi Asano∗2 , Hiroyuki Sato∗3 and Satoshi Teramukai∗4 ∗1東京大学大学院医学系研究科生物統計情報学講座 ∗2独立行政法人医薬品医療機器総合機構新薬審査第四部 ∗3独立行政法人医薬品医療機器総合機構新薬審査第五部 ∗4京都府立医科大学大学院医学研究科生物統計学 ∗1Department of Biostatistics and Bioinformatics, Graduate School of Medicine, The University of Tokyo, Tokyo 113-8654, Japan ∗2Office of New Drug IV, Pharmaceuticals and Medical Devices Agency, Tokyo 100-0013, Japan ∗3Office of New Drug V, Pharmaceuticals and Medical Devices Agency, Tokyo 100-0013, Japan ∗4Department of Biostatistics, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto 602-8566, Japan e-mail:hirakawa@m.u-tokyo.ac.jp

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Cancer Clinical Trials Based on Master Protocol

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Japanese journal of biometrics

自引率

0.00%

发文量